MFC Co., Ltd. (KRX:432980)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,500.00
-35.00 (-0.99%)
At close: Dec 18, 2025
-50.63%
Market Cap30.11B
Revenue (ttm)20.17B
Net Income (ttm)-1.19B
Shares Out8.59M
EPS (ttm)-155.66
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,557
Average Volume8,511
Open3,490.00
Previous Close3,535.00
Day's Range3,390.00 - 3,550.00
52-Week Range3,190.00 - 8,440.00
Betan/a
RSI43.79
Earnings Daten/a

About MFC Co., Ltd.

MFC Co., Ltd. operates as a pharmaceutical company in South Korea. The company specializes in research and development of pharmaceuticals; and provides materials and active pharmaceutical ingredients (APIs), pharmaceutical intermediates, and manufacturing services. MFC Co., Ltd. was incorporated in 2008 and is based in Hwaseong-si, South Korea. [Read more]

Industry Non-operating Establishments
Founded 2008
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 432980
Full Company Profile

Financial Performance

In 2024, MFC Co., Ltd.'s revenue was 20.60 billion, an increase of 19.04% compared to the previous year's 17.31 billion. Losses were -1.18 billion, 63.9% more than in 2023.

Financial Statements

News

There is no news available yet.